Another excellent write up, especially this part in the article :
Dr Andrew Stephens from the Hudson Institute of Medical Research in Melbourne has trialled a new photodynamic drug being developed by the Invion company IVX-PO2, a modified form of chlorophyll from plants, to kill ovarian cancer cells in petrie dishes.
“We’ve done lots of testing in the lab and it has been very effective at killing tumour cells. It’s not a case of will it or won’t it work, it’s a case of how effective it will be,” he said.
As I said early IMO, IVX deserves to be much higher than the current market cap. You can't keep a good dog down forever. It will bark and looks like its starting to bark now .
Some of you who insist to wait till human trial are successful before jumping in, then that is your choice because by then if its successfully then you will be paying the full price possibly multiples of the current share price. But then where is your upside ?
Remember Phrase III human trial is just around the corner, within the next 6 to 7 months according to IVX's time line.
IVX Price at posting:
1.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
.
(20min delay)